Feel Free Herbal Tonic Draws Backlash Over Undisclosed Side Effects

August 26, 2025 (New York) - Botanic Tonic’s latest wellness supplement, Feel Free, sparked a firestorm on social media today as users accused the company of failing to disclose known side effects. The controversy erupted on TikTok, where dozens of viral posts detailed adverse reactions including nausea, headaches and stomach cramps after consuming the herbal blend.

According to several TikTok creators, Feel Free’s marketing touted the tonic as an all-natural mood enhancer and energy booster, but made no mention of potential digestive or neurological symptoms. One video showing a user experiencing severe nausea amassed over 1.2 million views within hours. The hashtag #FeelFreeWarning trended nationally by midday, with consumers demanding greater transparency from Botanic Tonic.

In response to mounting criticism, Botanic Tonic released a brief statement late this afternoon acknowledging “isolated reports of discomfort” and committing to update packaging and product literature “to accurately reflect all known effects.” The company said it is working with a third-party laboratory to conduct an independent safety review and will post results on its website by September 15.

Meanwhile, the U.S. Food and Drug Administration confirmed it is monitoring the situation and reviewing consumer complaints related to Feel Free. An FDA spokesperson emphasized that dietary supplements are regulated under different standards than pharmaceuticals, but noted that companies must still provide truthful labeling and cannot omit known risks.

Industry analysts warn the incident could erode consumer trust in the fast-growing herbal supplement market, where minimal testing requirements have led to repeated safety questions. Feel Free’s controversy follows other high-profile supplement scares earlier this year, raising fresh calls for tighter oversight and clearer guidelines on ingredient disclosures.

As of today’s closing, Botanic Tonic shares were down 8% on the over-the-counter market, reflecting investor concerns over potential regulatory action and reputational damage. The company’s next earnings call is scheduled for September 10, where management is expected to address the fallout and outline steps to regain consumer confidence.